Determination of minimal residual disease in leukaemia patients

被引：138

作者：

Campana, D

机构：

[1] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA

[2] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA

[3] Univ Tennessee, Dept Pediat, Memphis, TN USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2003年 / 121卷 / 06期

关键词：

acute leukaemia; minimal residual disease; flow cytometry; PCR; quantitative PCR;

D O I：

10.1046/j.1365-2141.2003.04393.x

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

页码：823 / 838

页数：16

共 113 条

[1]

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL [J].

Bader, P ;

Hancock, J ;

Kreyenberg, H ;

Goulden, NJ ;

Niethammer, D ;

Oakhill, A ;

Steward, CG ;

Handgretinger, R ;

Beck, JF ;

Klingebiel, T .

LEUKEMIA, 2002, 16 (09) :1668-1672

[2]

High frequency of immunophenotype changes in acute myeloid leukemia at relapse:: implications for residual disease detection (Cancer and Leukemia Group B Study 8361) [J].

Baer, MR ;

Stewart, GC ;

Dodge, RK ;

Leget, G ;

Sulé, N ;

Mrózek, K ;

Schiffer, CA ;

Powel, BL ;

Kolitz, JE ;

Moore, JO ;

Stone, RM ;

Davey, FR ;

Carrol, AJ ;

Larson, RA ;

Bloomfield, CD .

BLOOD, 2001, 97 (11) :3574-3580

[3]

ANALYSIS OF IG AND T-CELL RECEPTOR GENES IN 40 CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS AT DIAGNOSIS AND SUBSEQUENT RELAPSE - IMPLICATIONS FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE BY POLYMERASE CHAIN-REACTION ANALYSIS [J].

BEISHUIZEN, A ;

VERHOEVEN, MAJ ;

VANWERING, ER ;

HAHLEN, K ;

HOOIJKAAS, H ;

VANDONGEN, JJM .

BLOOD, 1994, 83 (08) :2238-2247

[4]

Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias:: a new molecular target for detection of minimal residual disease [J].

Beishuizen, A ;

de Bruijn, MAC ;

Pongers-Willemse, MJ ;

Verhoeven, MAJ ;

van Wering, ER ;

Hählen, K ;

Breit, TM ;

de Bruin-Versteeg, S ;

Hooijkaas, H ;

van Dongen, JJM .

LEUKEMIA, 1997, 11 (12) :2200-2207

[5]

Combined analysis of morphology and fluorescence in situ hybridization in follow-up of minimal residual disease in a child with Philadelphia-positive acute lymphoblastic leukemia [J].

Bielorai, B ;

Golan, H ;

Trakhtenbrot, L ;

Reichart, M ;

Toren, A ;

Daniely, M ;

Zilberstein, Y ;

Amariglio, N ;

Rechavi, G ;

Kaplinsky, C .

CANCER GENETICS AND CYTOGENETICS, 2002, 138 (01) :64-68

[6]

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features.: A case control study of the International BFM study group [J].

Biondi, A ;

Valsecchi, MG ;

Seriu, T ;

D'Aniello, E ;

Willemse, MJ ;

Fasching, K ;

Pannunzio, A ;

Gadner, H ;

Schrappe, M ;

Kamps, WA ;

Bartram, CR ;

van Dongen, JJM ;

Panzer-Grümayer, ER .

LEUKEMIA, 2000, 14 (11) :1939-1943

[7]

Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia [J].

Boeckx, N ;

Willemse, MJ ;

Szczepanski, T ;

van der Velden, VHJ ;

Langerak, AW ;

Vandekerckhove, P ;

van Dongen, JJM .

LEUKEMIA, 2002, 16 (03) :368-375

[8]

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state [J].

Bounamici, S ;

Ottaviani, E ;

Testoni, N ;

Montefusco, V ;

Visani, G ;

Bonifazi, F ;

Amabile, M ;

Terragna, C ;

Ruggeri, D ;

Piccaluga, PP ;

Isidori, A ;

Malagola, M ;

Baccarani, M ;

Tura, S ;

Martinelli, G .

BLOOD, 2002, 99 (02) :443-449

[9]

IMMUNOLOGICAL MONITORING OF RESIDUAL DISEASE IN TREATED THYMIC ACUTE LYMPHOBLASTIC-LEUKEMIA [J].

BRADSTOCK, KF ;

JANOSSY, G ;

TIDMAN, N ;

PAPAGEORGIOU, ES ;

PRENTICE, HG ;

WILLOUGHBY, M ;

HOFFBRAND, AV .

LEUKEMIA RESEARCH, 1981, 5 (4-5) :301-309

[10]

Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia [J].

Brisco, MJ ;

Sykes, PJ ;

Hughes, E ;

Dolman, G ;

Neoh, SH ;

Peng, LM ;

Toogood, I ;

Morley, AA .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :314-319

← 1 2 3 4 5 6 7 8 9 10 →